Madrigal Pharmaceuticals Statistics

Total Valuation

MDGL has a market cap or net worth of $6.12 billion. The enterprise value is $5.18 billion.

Market Cap	6.12B
Enterprise Value	5.18B

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, before market open.

Earnings Date	Aug 6, 2024
Ex-Dividend Date	n/a

Share Statistics

MDGL has 21.31 million shares outstanding. The number of shares has increased by 9.97% in one year.

Shares Outstanding	21.31M
Shares Change (YoY)	+9.97%
Shares Change (QoQ)	+1.16%
Owned by Insiders (%)	15.17%
Owned by Institutions (%)	99.52%
Float	12.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	42.78
PB Ratio	7.20
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.39, with a Debt / Equity ratio of 0.14.

Current Ratio	9.39
Quick Ratio	n/a
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-30.26

Financial Efficiency

Return on equity (ROE) is -128.60% and return on invested capital (ROIC) is -46.90%.

Return on Equity (ROE)	-128.60%
Return on Assets (ROA)	-78.50%
Return on Capital (ROIC)	-46.90%
Revenue Per Employee	n/a
Profits Per Employee	-$1.18M
Employee Count	376
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +32.52% in the last 52 weeks. The beta is -0.43, so MDGL's price volatility has been lower than the market average.

Beta (5Y)	-0.43
52-Week Price Change	+32.52%
50-Day Moving Average	256.18
200-Day Moving Average	220.92
Relative Strength Index (RSI)	57.89
Average Volume (20 Days)	338,572

Short Selling Information

The latest short interest is 4.08 million, so 19.13% of the outstanding shares have been sold short.

Short Interest	4.08M
Short Previous Month	4.43M
Short % of Shares Out	19.13%
Short % of Float	32.57%
Short Ratio (days to cover)	6.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-454.20M
Pretax Income	-444.28M
Net Income	-444.28M
EBITDA	-429.49M
EBIT	-430.06M
Earnings Per Share (EPS)	-$23.13

Full Income Statement

Balance Sheet

The company has $1.06 billion in cash and $117.72 million in debt, giving a net cash position of $941.34 million or $44.17 per share.

Cash & Cash Equivalents	1.06B
Total Debt	117.72M
Net Cash	941.34M
Net Cash Per Share	$44.17
Equity (Book Value)	850.76M
Book Value Per Share	39.92
Working Capital	959.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$389.32 million and capital expenditures -$1.80 million, giving a free cash flow of -$391.12 million.

Operating Cash Flow	-389.32M
Capital Expenditures	-1.80M
Free Cash Flow	-391.12M
FCF Per Share	-$19.56

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MDGL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.97%
Shareholder Yield	-9.97%
Earnings Yield	-7.26%
FCF Yield	-6.39%

Dividend Details

Analyst Forecast

The average price target for MDGL is $348.50, which is 21.33% higher than the current price. The consensus rating is "Buy".

Price Target	$348.50
Price Target Difference	21.33%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 25, 2016. It was a reverse split with a ratio of 1:35.

Last Split Date	Jul 25, 2016
Split Type	Reverse
Split Ratio	1:35

Scores

Altman Z-Score	n/a
Piotroski F-Score	2